Leading Precision Medicine In South East Asia (SEA)
Pathomics Health focuses on advanced precision medicine diagnostics and digital healthcare solutions to provide patients access to better outcome.
EarlyCDT-Lung
The EarlyCDT ® Lung is a CE-IVD and HSA-approved diagnostic test that uses a blood sample to detect a panel of seven lung cancer autoantibodies in humans. The test aids in the early detection of lung cancer in high-risk individuals and in the assessment of risk in patients with indeterminate pulmonary nodules identified through CT scans.
DNlite-DKD
The DNlite-DKD test is an in-vitro diagnostic test approved by the Health Sciences Authority (HSA). It is designed to assist clinicians in assessing the risk of kidney function decline in individuals with Type 2 diabetes who show signs of albuminuria (protein in the urine). The test is used alongside clinical evaluations for a more comprehensive prognosis.

Leading Precision Medicine In South East Asia (Sea)
Our Mission
Advancing Diagnostics & Digital Health Solutions for Better Health
Our Vision
Universal Accessibility to Affordable Precision Diagnostics & Screening
We offer an innovative, scalable and cost-effective advanced diagnostics platform, combining with cutting-edge technology and design to help patients and individuals to improve their health.
Our Commitment

Company Milestones - Driving Excellence Since 2017
-
Nov 2022
Clinical Laboratory Obtains MOH License in Singapore
-
Aug 2022
MAHSA Health Collaboration
-
Aug 2022
Pacific Insurance Collaboration
-
Aug 2022
MiCare Collaboration
-
Feb 2022
Official Opening of Laboratory in Singapore
-
Nov 2017
Launching of GEMS@UM Laboratory
Our Laboratories
